What is Delcath Systems's R&D?

Delcath Systems (DCTH) reported R&D of $9.82M in Q1 2026.

How has Delcath Systems's R&D changed year-over-year?

Delcath Systems's R&D increased by 96.2% year-over-year, from $5.01M to $9.82M.

What is the long-term trend for Delcath Systems's R&D?

Over 4 years (2021 to 2025), Delcath Systems's R&D has grown at a 20.7% compound annual growth rate (CAGR), from $13.78M to $29.25M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

Delcath Systems DCTH R&D

R&D at other companies

Merit Medical SystemsMMSI

$22.61M+0.6%

AltimmuneALT

$16.19M+2.3%

Rigel PharmaceuticalsRIGL

$11.68M+38.4%

Wave Life SciencesWVE

$47.44M+16.8%

Mirum Pharmaceuticals, Inc.MIRM

$97.91M+139%

ImmunomeIMNM

$46.38M+25.8%

Other financials

Income statement

See full

Revenue$25.0M+26.3%

Gross profit$21.3M+25.5%

Operating income-$1.6M-355%

Net income-$1.1M-200%

EPS (diluted)-$0.03-200%

Balance sheet

See full

Cash & equivalents$41.3M+223%

Total debt$907.0K-10.7%

Total equity$112.7M+40.5%

Total assets$124.8M+43.0%

Cash flow

See full

Operating cash flow$857.0K-61.1%

CapEx$570.0K+307%

Free cash flow$287.0K-86.1%

Valuation

See full

Market cap$425.31M-11.8%

Enterprise value$384.91M-18.2%

P/E120.6×—

P/S4.7×-4.3×

Profitability

See full

Gross margin86%+1.1pp

Operating margin-118.1%-56.8pp

Net margin1.5%+0.8pp

FCF margin21.2%+15.2pp

Returns & leverage

See full

Return on equity1.9%+1.0pp

Debt / equity0×0.0×

Current ratio11.2×-4.7×

Where this comes from

Reported directly by Delcath Systems in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Delcath Systems’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Delcath Systems's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Delcath Systems's R&D?: Delcath Systems (DCTH) reported R&D of $9.82M in Q1 2026.
How has Delcath Systems's R&D changed year-over-year?: Delcath Systems's R&D increased by 96.2% year-over-year, from $5.01M to $9.82M.
What is the long-term trend for Delcath Systems's R&D?: Over 4 years (2021 to 2025), Delcath Systems's R&D has grown at a 20.7% compound annual growth rate (CAGR), from $13.78M to $29.25M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.